CNTO1275CRD1003: A Phase 1, Open-label, Drug Interaction Study to Evaluate the Effect of Ustekinumabon Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants withModerate to Severe Crohn???s Disease

Project: Research project

Project Details

Description

CNTO1275CRD1003: A Phase 1, Open-label, Drug Interaction Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants with Moderate to Severe Crohn???s Disease
StatusFinished
Effective start/end date5/1/19 → 6/30/24

Funding

  • JANSSEN RESEARCH & DEVELOPMENT, LLC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint